Free Trial

Ryan Specialty (RYAN) Competitors

Ryan Specialty logo
$56.47 -0.18 (-0.31%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$55.02 -1.46 (-2.58%)
As of 08/29/2025 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RYAN vs. MFC, PUK, SLF, WTW, CRBG, PFG, EQH, AEG, BNT, and EG

Should you be buying Ryan Specialty stock or one of its competitors? The main competitors of Ryan Specialty include Manulife Financial (MFC), Prudential Public (PUK), Sun Life Financial (SLF), Willis Towers Watson Public (WTW), Corebridge Financial (CRBG), Principal Financial Group (PFG), Equitable (EQH), Aegon (AEG), Brookfield Wealth Solutions (BNT), and Everest Group (EG). These companies are all part of the "insurance" industry.

Ryan Specialty vs. Its Competitors

Ryan Specialty (NYSE:RYAN) and Manulife Financial (NYSE:MFC) are both large-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Manulife Financial has higher revenue and earnings than Ryan Specialty. Manulife Financial is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ryan Specialty$2.81B5.29$94.67M$0.35161.35
Manulife Financial$38.90B1.34$4.11B$2.2413.74

Ryan Specialty has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500. Comparatively, Manulife Financial has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500.

Ryan Specialty currently has a consensus target price of $74.83, indicating a potential upside of 32.51%. Manulife Financial has a consensus target price of $48.50, indicating a potential upside of 57.54%. Given Manulife Financial's higher probable upside, analysts plainly believe Manulife Financial is more favorable than Ryan Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ryan Specialty
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75
Manulife Financial
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Manulife Financial has a net margin of 10.46% compared to Ryan Specialty's net margin of 6.81%. Ryan Specialty's return on equity of 48.70% beat Manulife Financial's return on equity.

Company Net Margins Return on Equity Return on Assets
Ryan Specialty6.81% 48.70% 5.59%
Manulife Financial 10.46%15.77%0.74%

In the previous week, Ryan Specialty had 2 more articles in the media than Manulife Financial. MarketBeat recorded 10 mentions for Ryan Specialty and 8 mentions for Manulife Financial. Manulife Financial's average media sentiment score of 1.48 beat Ryan Specialty's score of 1.22 indicating that Manulife Financial is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ryan Specialty
9 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Manulife Financial
8 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ryan Specialty pays an annual dividend of $0.48 per share and has a dividend yield of 0.8%. Manulife Financial pays an annual dividend of $1.27 per share and has a dividend yield of 4.1%. Ryan Specialty pays out 137.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Manulife Financial pays out 56.7% of its earnings in the form of a dividend. Ryan Specialty has raised its dividend for 1 consecutive years and Manulife Financial has raised its dividend for 12 consecutive years. Manulife Financial is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 52.6% of Manulife Financial shares are owned by institutional investors. 52.2% of Ryan Specialty shares are owned by insiders. Comparatively, 0.0% of Manulife Financial shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Manulife Financial beats Ryan Specialty on 10 of the 19 factors compared between the two stocks.

Get Ryan Specialty News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYAN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYAN vs. The Competition

MetricRyan SpecialtyINS IndustryFinance SectorNYSE Exchange
Market Cap$14.89B$26.19B$12.49B$21.25B
Dividend Yield0.85%1.16%5.42%3.50%
P/E Ratio161.3648.77229.1229.33
Price / Sales5.294.8231.9969.27
Price / Cash21.3931.9819.0618.27
Price / Book13.484.792.314.58
Net Income$94.67M$835.86M$1.01B$997.71M
7 Day Performance-2.76%1.34%0.53%0.77%
1 Month Performance-2.58%5.57%4.55%6.95%
1 Year Performance-12.62%-3.50%541.64%11.66%

Ryan Specialty Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RYAN
Ryan Specialty
4.8512 of 5 stars
$56.47
-0.3%
$74.83
+32.5%
-12.6%$14.89B$2.81B161.365,250Positive News
MFC
Manulife Financial
4.8526 of 5 stars
$30.09
-2.1%
$48.50
+61.2%
+11.5%$52.21B$38.90B13.4337,000Positive News
PUK
Prudential Public
3.5659 of 5 stars
$26.77
-1.1%
N/A+54.2%$34.86B$16.66B11.5415,412News Coverage
Positive News
Dividend Announcement
Analyst Downgrade
SLF
Sun Life Financial
4.8087 of 5 stars
$58.10
-1.4%
$88.00
+51.5%
+7.2%$33.18B$28.32B14.3831,768Positive News
WTW
Willis Towers Watson Public
4.1937 of 5 stars
$336.46
-0.8%
$362.92
+7.9%
+11.9%$33.09B$9.93B19.9048,900Dividend Announcement
CRBG
Corebridge Financial
4.6583 of 5 stars
$34.67
-0.9%
$40.70
+17.4%
+17.6%$18.83B$19.58B6.825,200Positive News
PFG
Principal Financial Group
3.2371 of 5 stars
$80.28
-0.5%
N/AN/A$17.98B$16.13B10.5219,700
EQH
Equitable
3.7832 of 5 stars
$52.88
-1.3%
$64.90
+22.7%
+25.3%$16.05B$12.44B42.648,000Positive News
AEG
Aegon
4.6257 of 5 stars
$7.85
-1.4%
N/A+27.7%$15.97B$10.65B8.1823,123Analyst Upgrade
BNT
Brookfield Wealth Solutions
N/A$64.87
-1.5%
N/AN/A$15.83B$14.10B190.805,000
EG
Everest Group
4.8231 of 5 stars
$341.21
-0.8%
$397.14
+16.4%
-12.8%$14.43B$17.28B18.113,037Positive News

Related Companies and Tools


This page (NYSE:RYAN) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners